• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by TIAN RUIXIANG Holdings Ltd

    1/8/25 5:27:59 PM ET
    $TIRX
    Specialty Insurers
    Finance
    Get the next $TIRX alert in real time by email
    6-K 1 tm252696d1_6k.htm FORM 6-K

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of January 2025

     

    Commission File Number: 001- 39925

     

    TIAN RUIXIANG Holdings Ltd.

     

    Room 918, Jingding Building,

    Xicheng District, District, Beijing,

    Xicheng District, District, Beijing, People’s Republic of China

    (Address of principal executive offices)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

    Form 20-F x      Form 40-F ¨

     

     

     

     

     

      

    Entry Into Material Definitive Agreements

     

    On January 6, 2025, TIAN RUIXIANG Holdings Ltd., an exempted company with limited liability formed in the Cayman Islands (the “Company”), entered into five agreements (the “Agreements”) with five creditors (each, a “Creditor”, and collectively, the “Creditors”) to convert debts owed by the Company to the Creditors into the Company’s Class A ordinary shares, par value 0.025 per share (the “Ordinary Share”), at a conversion price of $1.63 per share, which is the average closing price of the Ordinary Shares on Nasdaq for the 15 trading days leading up to and including December 31, 2024. Pursuant to the Agreements, the Company agreed to issue an aggregate of 1,355,568 Ordinary Shares (the “Shares”) to the Creditors to fully settle debts in the amount of $2,209,575 (the “Debts”) no later than January 26, 2025, and the Creditors agreed that, upon the issuance of the Shares, the Company’s obligations with respect to the Debts will be fully and completely satisfied. The Shares will be issued under Regulation S promulgated by the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended. The Company’s board of directors has duly approved the entry into the Agreements and the transactions outlined therein.

     

    The foregoing description of the Agreements are qualified in their entirety by reference to the full text of the Agreements, which are furnished hereto as Exhibits 10.1-10.5.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      TIAN RUIXIANG Holdings Ltd.
         
    Date: January 8, 2025 By:

    /s/ Sheng Xu

      Name: Sheng Xu
      Title: Chief Executive Officer

     

     

     

     

    EXHIBIT INDEX

     

    Exhibit No.  Description
    10.1  Debt Conversion Agreement dated January 6, 2025 by and between the Company and Fenge Feng
    10.2  Debt Conversion Agreement dated January 6, 2025 by and between the Company and Wang Zhe
    10.3  Debt Conversion Agreement dated January 6, 2025 by and between the Company and Mufang Gao
    10.4  Debt Conversion Agreement dated January 6, 2025 by and between the Company and Baohai Xu
    10.5  Debt Conversion Agreement dated January 6, 2025 by and between the Company and Mingxiu Luan

     

     

     

    Get the next $TIRX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TIRX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $TIRX
    Financials

    Live finance-specific insights

    See more
    • TIAN RUIXIANG Holdings Ltd Reports Financial Results for the Half Year Ended April 30, 2024

      BEIJING, Aug. 16, 2024 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company"), a China-based insurance broker conducting business through its variable interest entity in China, today announced its financial results for the half year ended April 30, 2024. Ms. Sheng Xu, the Chief Executive Officer of the Company, commented, "The Company reported a net loss of approximately $2.6 million for the six months ended April 30, 2024, primarily due to a significant decline in revenue caused by the loss of a few key insurance company partners. However, we are encouraged by the increase in the commissions from liability insurance of approximately $24,000 compared to t

      8/16/24 4:15:15 PM ET
      $TIRX
      Specialty Insurers
      Finance
    • TIAN RUIXIANG Holdings Ltd Announces 2021 Performance Incentive Plan

      BEIJING, Dec. 8, 2021 /PRNewswire/ -- TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the "Company"), a China-based insurance broker, announced today that the Company adopted a performance incentive plan (the "2021 Plan") to motivate and reward eligible employees based on their performance.  The Company has also filed a registration statement on Form S-8 (the "Registration Statement") to register 5,000,000 Class A ordinary shares, par value of US$0.001 per share (the "Class A Ordinary Shares"), of the Company, issuable pursuant to the the 2021 Plan. In accordance with Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement also covers an indete

      12/8/21 9:00:00 AM ET
      $TIRX
      Specialty Insurers
      Finance

    $TIRX
    SEC Filings

    See more
    • SEC Form 6-K filed by TIAN RUIXIANG Holdings Ltd

      6-K - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

      5/30/25 6:04:39 AM ET
      $TIRX
      Specialty Insurers
      Finance
    • SEC Form 20-F filed by TIAN RUIXIANG Holdings Ltd

      20-F - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

      1/31/25 4:30:45 PM ET
      $TIRX
      Specialty Insurers
      Finance
    • SEC Form 6-K filed by TIAN RUIXIANG Holdings Ltd

      6-K - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

      1/29/25 8:45:58 AM ET
      $TIRX
      Specialty Insurers
      Finance

    $TIRX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by TIAN RUIXIANG Holdings Ltd

      SC 13G/A - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

      11/13/24 11:16:48 AM ET
      $TIRX
      Specialty Insurers
      Finance
    • SEC Form SC 13D filed by TIAN RUIXIANG Holdings Ltd

      SC 13D - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

      6/10/24 6:15:45 AM ET
      $TIRX
      Specialty Insurers
      Finance
    • SEC Form SC 13D/A filed by TIAN RUIXIANG Holdings Ltd (Amendment)

      SC 13D/A - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

      6/10/24 6:08:20 AM ET
      $TIRX
      Specialty Insurers
      Finance

    $TIRX
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $TIRX
    Leadership Updates

    Live Leadership Updates

    See more
    • TIAN RUIXIANG Holdings Ltd to Acquire Ucare Inc. in US$150 Million All-Stock Deal, Advancing In-Hospital Health Insurance Strategy

      BEIJING, May 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company" or "TRX"), a China-based insurance broker, today announced plans to acquire 100% of issued and outstanding shares of Ucare Inc. ("Ucare"), the sole operator of China's only cloud-based AI-driven hospital and health insurance risk management platform, in an all-share deal valued at US$150 million. This strategic move aims to unlock new growth opportunities in the health insurance segment. The Company and its wholly-owned subsidiary, VitaCare Limited ("VitaCare") have entered into a share exchange agreement (the "Agreement") with certain shareholders (the "Sellers") of Ucare and other parties.

      5/30/25 6:10:00 AM ET
      $TIRX
      Specialty Insurers
      Finance
    • TIAN RUIXIANG Holdings Ltd Reports Financial Results for the Half Year Ended April 30, 2024

      BEIJING, Aug. 16, 2024 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company"), a China-based insurance broker conducting business through its variable interest entity in China, today announced its financial results for the half year ended April 30, 2024. Ms. Sheng Xu, the Chief Executive Officer of the Company, commented, "The Company reported a net loss of approximately $2.6 million for the six months ended April 30, 2024, primarily due to a significant decline in revenue caused by the loss of a few key insurance company partners. However, we are encouraged by the increase in the commissions from liability insurance of approximately $24,000 compared to t

      8/16/24 4:15:15 PM ET
      $TIRX
      Specialty Insurers
      Finance
    • TIAN RUIXIANG Holdings Ltd Regains Compliance with Nasdaq's Periodic Filing Requirement

      BEIJING, July 23, 2024 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company"), a China-based insurance broker conducting business through its variable interest entity in China, today announced that the Company received a written notification from the Nasdaq Stock Market LLC ("Nasdaq") on July 18, 2024, informing the Company that it has regained compliance with Nasdaq's periodic filing requirement set forth under Listing Rule 5250(c)(1), because the Company had filed its annual report on Form 20-F for the period ended October 31, 2023 on July 17, 2024. About TIAN RUIXIANG Holdings Ltd TIAN RUIXIANG Holdings Ltd, headquartered in Beijing, China, is an insurance broker

      7/23/24 8:30:00 AM ET
      $TIRX
      Specialty Insurers
      Finance
    • TIAN RUIXIANG Holdings Ltd to Acquire Ucare Inc. in US$150 Million All-Stock Deal, Advancing In-Hospital Health Insurance Strategy

      BEIJING, May 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company" or "TRX"), a China-based insurance broker, today announced plans to acquire 100% of issued and outstanding shares of Ucare Inc. ("Ucare"), the sole operator of China's only cloud-based AI-driven hospital and health insurance risk management platform, in an all-share deal valued at US$150 million. This strategic move aims to unlock new growth opportunities in the health insurance segment. The Company and its wholly-owned subsidiary, VitaCare Limited ("VitaCare") have entered into a share exchange agreement (the "Agreement") with certain shareholders (the "Sellers") of Ucare and other parties.

      5/30/25 6:10:00 AM ET
      $TIRX
      Specialty Insurers
      Finance